Cargando…

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study

OBJECTIVE: The objective of this study is to compare all-cause in-hospital mortality in preterm infants with respiratory distress syndrome (RDS) treated with poractant alfa, calfactant or beractant. STUDY DESIGN: A retrospective cohort study of 14 173 preterm infants with RDS, treated with one of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramanathan, R, Bhatia, J J, Sekar, K, Ernst, F R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558698/ https://www.ncbi.nlm.nih.gov/pubmed/21886094 http://dx.doi.org/10.1038/jp.2011.125

Ejemplares similares

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015)

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
por: Sánchez Luna, Manuel, et al.
Publicado: (2020)

In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
por: Ricci, Francesca, et al.
Publicado: (2017)

Less invasive beractant administration in preterm infants: a pilot study
por: Ramos-Navarro, Cristina, et al.
Publicado: (2016)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020)

In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits
por: Guo, Xiaojing, et al.
Publicado: (2020)

Poractant alfa (Curosurf(®)) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
por: Willems, Coen HMP, et al.
Publicado: (2012)

Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets
por: Rey-Santano, Carmen, et al.
Publicado: (2020)

Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
por: Królak-Olejnik, Barbara, et al.
Publicado: (2020)

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial
por: Lemyre, Brigitte, et al.
Publicado: (2017)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

A Review on Non-invasive Respiratory Support for Management of Respiratory Distress in Extremely Preterm Infants
por: Shi, Yuan, et al.
Publicado: (2020)

Lung Beractant Increases Free Cytosolic Levels of Ca(2+) in Human Lung Fibroblasts
por: Guzmán-Silva, Alejandro, et al.
Publicado: (2015)

Less Invasive Surfactant Administration: A Review of Current Evidence of Clinical Outcomes With Beractant
por: Sanchez Luna, Manuel, et al.
Publicado: (2022)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Assessment of hemodynamic changes in preterm infants with respiratory distress syndrome
por: Özdemir, Senem Alkan, et al.
Publicado: (2017)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Glucocorticoids, sodium transport mediators, and respiratory distress syndrome in preterm infants
por: Süvari, Liina, et al.
Publicado: (2020)

Lung ultrasonography of pulmonary complications in preterm infants with respiratory distress syndrome
por: Lovrenski, Jovan
Publicado: (2012)

Bubble–CPAP vs. Ventilatory–CPAP in Preterm Infants with Respiratory Distress
por: Bahman-Bijari, Bahareh, et al.
Publicado: (2011)

Association between Thyroid Function and Respiratory Distress Syndrome in Preterm Infants
por: Kim, Yonghyuk, et al.
Publicado: (2022)

Feasibility of ultrasound in the diagnosis of neonatal respiratory distress syndrome in preterm infants
por: Zheng, Lei, et al.
Publicado: (2023)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Increased risk for respiratory distress among white, male, late preterm and term infants
por: Anadkat, J S, et al.
Publicado: (2012)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
por: Jeon, Ga Won
Publicado: (2019)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
por: Jo, Heui Seung
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

2612. Molecular Evidence of Ureaplasma urealyticum and Ureaplasma parvum Colonization in Preterm Infants with Respiratory Distress
por: Kumar, Surinder, et al.
Publicado: (2019)

Non-invasive administration of poractant-α in neonatal respiratory distress syndrome via a supraglottic device in the clinical practice in a second level neonatal unit: comparison of LMA® vs iGel® devices
por: Parmigiani, Stefano, et al.
Publicado: (2022)

Nasal Continuous Positive Airway Pressure with Heliox in Preterm Infants with Respiratory Distress Syndrome
por: Mosalli, Rafat
Publicado: (2012)

Predictor Factors of Continuous Positive Airway Pressure Failure in Preterm Infants with Respiratory Distress
por: Permatahati, Winda Intan, et al.
Publicado: (2021)

Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021)

Effects of Chest Physiotherapy in Preterm Infants with Respiratory Distress Syndrome: A Systematic Review
por: Igual Blasco, Ana, et al.
Publicado: (2023)

Early Respiratory Management of Respiratory Distress Syndrome in Very Preterm Infants and Bronchopulmonary Dysplasia: A Case-Control Study
por: te Pas, Arjan B., et al.
Publicado: (2007)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
por: Toma, Andrew, et al.
Publicado: (2021)

Non-invasive High-Frequency Oscillatory Ventilation as Initial Respiratory Support for Preterm Infants With Respiratory Distress Syndrome
por: Lai, Shu-Hua, et al.
Publicado: (2022)

Plasma Cytokine Levels Fall in Preterm Newborn Infants on Nasal CPAP with Early Respiratory Distress
por: Carvalho, Clarissa Gutierrez, et al.
Publicado: (2015)

Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study
por: Olivier, François, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_166ui2093tmlhcc8po4mrvucuo